OXYTROL (Allergan, Inc.)
Welcome to the PulseAid listing for the OXYTROL drug offered from Allergan, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allergan, Inc. |
NON-PROPRIETARY NAME: | Oxybutynin |
SUBSTANCE NAME: | OXYBUTYNIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | PATCH |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-02-26 |
END MARKETING DATE: | 0000-00-00 |
OXYTROL HUMAN PRESCRIPTION DRUG Details:
Item Description | OXYTROL from Allergan, Inc. |
LABELER NAME: | Allergan, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3.9(mg/d) |
START MARKETING DATE: | 2003-02-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0023-6153_f36f3819-927f-4ec6-a42e-333af9a6907a |
PRODUCT NDC: | 0023-6153 |
APPLICATION NUMBER: | NDA021351 |
Other OXYBUTYNIN Pharmaceutical Manufacturers / Labelers: